Abstract
Among different diagnostic techniques, Raman spectroscopy has been studied as a promising new tool for real time diagnostic. In this study we conducted Raman experiments in vivo and/or ex vivo in a high incidence of tumors and / or mortality rate. The in vivo transcutaneous breast measurements for normal and abnormal tissues were correctly classified with a discriminant proportion of 73%, whereas for the in vivo skin removal the discriminant proportion reached 86%. For ex vivo breast cancer the specificity and sensitivity values are around 96% and 92%, respectively.
© 2010 Optical Society of America
PDF ArticleMore Like This
Zoya Volynskaya, Maryann Fitzmaurice, Robert Shenk, Marjie Persons, Wendy Liu, Ramachandra R. Dasari, and Michael S. Feld
BTuD114p Biomedical Optics (BIOMED) 2010
Zhiwei Huang, Wei Zheng, and Sheppard Colin
TuC4 European Conference on Biomedical Optics (ECBO) 2005
Nancy Wang, Nina Klein, Robert Shenk, Maryann Fitzmaurice, Joanne Woletz, David Hicks, Joseph P. Crowe, Abigail S. Haka, Zoya Volynskaya, Jason T. Motz, Joseph A. Gardecki, Jonathon Nazemi, Ramachandra R. Dasari, and Michael S. Feld
TuC1 European Conference on Biomedical Optics (ECBO) 2005